Discover our new Multiplex SARS-CoV-2 Influenza A/B CE IVD kit
We are improving molecular diagnostics
Fast and Robust DNA/RNA Isolation
Unique Sample Collection System
PCR Diagnostics of Viruses
NGS Sequencing Uncovering the Infections
Complete solution for SARS-CoV-2 detection
PCR Multiplex for COVID-INFA-INFB
Manufactured in Europe
We are improving molecular diagnostics
Fast and Robust DNA/RNA Isolation
Unique Sample Collection System
PCR Diagnostics of Viruses
NGS Sequencing Uncovering the Infections
Complete solution for SARS-CoV-2 detection
PCR Multiplex for COVID-INFA-INFB
Manufactured in Europe
Everything we do is driven by a desire to improve quality of life. Our purpose is to deliver innovation into molecular diagnostics.
Everything we do is driven by a desire to improve quality of life. Our purpose is to deliver innovation into molecular diagnostics.
GENESPECTOR IS FOCUSED ON SERVING THE UNMET COVID-19 LABORATORY TESTING NEEDS
GeneSpector provides a unique solution for rapid Covid-19 detection.
- viRNAtrap™ Collection Tube inactivates the infectious agents developed for save operations at ambient temperature
- viRNAtrap™ Extraction Kit (CE IVD) is a best-in-class solution for fast and high throughput extraction at any open automated platform or when using manual work-up
- high-quality CE IVD PCR kits for fast COVID-19 detection
- triplex COVID-INFA-INFB
Flexibility of the range of our products allows implementation into any single laboratory.
Discover our products AND pipeline
Collection Tubes
We have developed a unique DNA/RNA transport and storage medium that immediately inactivates the viruses ensuring safety of your laboratory personnel. It does not matter whether you have your own PCR machine or you get your samples analysed externally. viRNAtrap™ Collection Tubes preserve the genetic integrity of samples at ambient temperature for weeks.
Extraction Kit
Our fast and robust nucleic acid extraction is based on magnetic beads technology. viRNAtrap™ Extraction Kit can be used for manual and automated nucleic acid purification on any open platform. The kit consists of 4 bottles not requiring controlled temperature storage. The isolation process takes 10 minutes only and enables true high-throughput extraction.
PCR Diagnostics
We have developed a high-quality PCR kit for rapid COVID-19 detection. The protocol is designed for about 60 minutes run time that allows laboratories to deliver the results much faster to patients and doctors.
Our break-trough triplex PCR kit of COVID-INFA-INFB will provide fast confirmation of the infection type. All kits are CE IVD certified.
NGS SEQUENCING
We are developing and optimizing a next-generation sequencing (NGS)-based methods that enable rapid and robust identification of pathogens in nasal swabs and other similar clinically relevant materials.
This protocol may thus rapidly identify whole spectrum of pathogens in clinical materials and may help in differential diagnosis and specific treatment of patients with various types of infectious diseases.
UNDER DEVELOPMENT
Our goal is to improve molecular diagnostics. We work towards expanding our testing flow beyond COVID-19, targeting detection of other infectious diseases.
New PCR kits
Q4 2020
- 80%
viRNAtrap™ Extraction Kit for full blood, serum, and plasma
Q1 2021
- 30%
New approach for Sample Collection
Q2 2021
- 10%
UNDER DEVELOPMENT
Our goal is to improve molecular diagnostics. We work towards expanding our testing flow beyond COVID-19, targeting detection of other infectious diseases.
viRNAtrap™ Extraction Kit for saliva
November 2020
- 95%
viRNAtrap™ Collection Tube – certification CE IVD
Q4 2020
- 90%
viRNAtrap™ Extraction Kit – certification CE IVD
Q4 2020
- 90%
viRNAtrap™ Extraction Kit for full blood, serum, and plasma
Q1 2021
- 30%
New approach for Sample Collection
Q2 2021
- 10%
NEWS AND MEDIA
Introducing the long-awaited test for COVID-19 and Influenza A & B
Press release
CU subsidiary GeneSpector introduces new kits to detect Covid-19
Technology to diagnose, safely isolate and neutralise Covid samples was developed at Charles University
Charles University, private sector, develop new test for Covid-19 and flu
A team of researchers from Charles University’s First Faculty of Medicine together with the private sector firms have developed a new test for flu and Covid-19 which should be available in September.
Charles University develops test to distinguish influenza from coronavirus – Human – Science and technology
Charles University develops test to distinguish influenza from coronavirus – Human – Science and technology
Prague’s Charles University is developing a joint coronavirus/flu test, to be launched next month
The test might also deliver results twice as fast as current PCR tests, university officials have announced
There could be a joint test for influenza and COVID-19 by next month
Charles University is developing a joint test with the private sector for influenza and coronavirus. The test could be on the market as soon as mid-September.
NEWS AND MEDIA
Prague’s Charles University is developing a joint coronavirus/flu test, to be launched next month
The test might also deliver results twice as fast as current PCR tests, university officials have announced
There could be a joint test for influenza and COVID-19 by next month
Charles University is developing a joint test with the private sector for influenza and coronavirus. The test could be on the market as soon as mid-September.
Partnering
We have designed our viRNAtrap™ Collection Tubes, viRNAtrap™ Extraction Kit, PCR kit for rapid COVID-19 detection to fit the needs of any laboratory. Our system provides a robust and safe solution for high-throughput COVID-19 diagnostics. therefore, We are open to expand our current customer base by partnering with global players and/or channel partners from all geographies. Get in touch with us.
We are improving molecular diagnostics
PetrskA 1180/3 Praha 1
Czech Republic
info@genespector.com